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Abstract
Background: Effective management of menopause is an important way to improve the quality of
life of the increasing number of older women. The study sought to find out if Nigerian
Gynaecologists offer effective treatment for severe menopausal symptoms.
Methods:  126 Nigerian Gynaecologists representing the six health zones of Nigeria were
interviewed to determine the menopausal symptoms they had ever encountered in their practices,
frequency of the symptoms, treatments ever offered for severe symptoms including their attitude
to, and practice of hormone replacement therapy.
Results:  A Nigerian Gynaecologist encountered an average of one patient with menopausal
symptoms every three months (range: 0-3 patients per month). The commoner symptoms they
encountered were hot flushes (88%), insomnia (75.4%), depression (58.0%), irritability (56.3%),
night sweats (55.6%) and muscle pains (54.8%) while urinary symptoms (16.7%) and fracture (1.6%)
were less common. Treatments ever offered for severe symptoms were reassurance (90.5%),
anxiolytics (68.3%), analgesics (14.3), HRT (7.9%), Vitamins (4%), Beta-blockers (3.2%) and Danazol
(2.4%). These treatments were offered as a matter of institutional traditions rather than being
based on any evidence of their efficacy.
Conclusion:  The result revealed that most Nigerian Gynaecologists prefer reassurance and
anxiolytics for managing severe menopausal symptoms instead of evidence-based effective
therapies. A policy of mandatory continuing medical education for Nigerian physicians is
recommended to ensure evidence-based management of gynaecological problems, including
menopause.
Background
Effective management of menopause is necessary to
improve the quality of life of the growing population of
menopausal women. The increasing life expectancy in
most societies means that more than ever before, women
are now attaining menopause and spending more years in
a state of ovarian failure. The age of menopause has
remained constant at about 51 ± 3 years [1-3]. With an
average life expectancy of 82 years in Britain for instance,
an average woman now spends about a third of her life-
time in the menopausal state. Ovarian failure is associated
with profound changes which have both short term and
long term consequences for the woman's quality of life
[4]. Relatively simple hormone treatments are effective for
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this condition [4-6]. Non-hormonal treatments have also
been employed for many years with varying degrees of
reported successes [4,7-10]. However, only hormone
replacement therapy (HRT) is believed to address the root
cause of the symptoms, and has proved effective for symp-
tomatic relief as well as for prevention of the long term
sequellae of menopause [4,11,12]. HRT remains the refer-
ence standard for assessing the effectiveness of non-hor-
monal interventions. The results of the Women's Health
Initiative Survey [13] and subsequent studies [14,15],
have revealed evidences of increased risks of breast cancer,
stroke and pulmonary embolism in association with long
term use of hormone replacement therapy. HRT is how-
ever still considered justifiable and indeed recommended
for symptomatic relief of severe menopausal symptoms
although it is no longer recommended for long-term
prophylaxis [5,14-16]. Physicians who care for women are
expected to be familiar with evidence-based effective and
safe management of menopause.
In Nigeria, there is dearth of information on the subject
menopause. Because few women presented to hospital
with menopausal symptoms, it was assumed in the past
that most Nigerian women did not develop menopausal
symptoms or that the symptoms were so mild that the
women could cope without medical treatment. Hence, the
average Nigeria-trained physician did not consider meno-
pausal symptoms as important health problems. Recent
community-based studies [17,18] have revealed that most
menopausal symptoms are indeed prevalent amongst
Nigerian women. Because of cultural practices that engen-
der positive attitude to menopause in some Nigerian com-
munities [17], women with mild menopausal symptoms
are able to cope with the symptoms without seeking for
treatment. However, women with moderate and severe
menopausal symptoms consider them important health
concerns and seek treatment for these symptoms. Accord-
ing to Agwu et.al [18] women who consulted physicians
for menopausal symptoms were not offered effective treat-
ments of their symptoms whereas those who consulted
the herbal medicine practitioners were offered more effec-
tive herbal therapies most of which consisted of phytoes-
trogen preparations. As a result, the botanical
preparations are very popular among the menopausal
women while hospital consultations for menopausal
symptoms are unpopular. Could the paucity of hospital
consultations for menopausal symptoms in Nigeria be the
result of ineffective hospital-based treatment of these
symptoms? The overall objective of this study was to
determine whether or not Nigerian Gynaecologists offer
effective and evidence-based treatment of severe meno-
pausal symptoms. The specific objectives were to deter-
mine the menopausal symptoms ever encountered by
Nigerian Gynaecologists in their practices, the relative fre-
quencies of the symptoms, the types of treatment they had
ever offered for severe menopausal symptoms and their
attitude to, and practice of hormone replacement therapy.
The results of the study are expected to be particularly use-
ful to the Society of Gynaecology and Obstetrics of Nigeria
(SOGON) and the Postgraduate Medical Colleges in their
respective functions of regulating gynaecology practice
and training of Gynaecologists in Nigeria.
Methods
This cross sectional study was conducted amongst Nige-
rian Gynaecologists who were attending an annual confer-
ence. The study population was the 540 Gynaecologists in
the register of the Society of Gynaecology and Obstetrics
of Nigeria (SOGON) in 2006 [19]. A minimum sample
size of 109, representing 20% of study population was
considered an adequate representative of the study popu-
lation. In order to ensure proportionate representation,
the respondents were first stratified into 6 according to the
6 health zones of Nigeria. Next, 20% of the registered
members of SOGON from each health zone was calcu-
lated to obtain the minimum sample size for the corre-
sponding zone. The calculated minimum sample sizes for
the 6 health zones were as follow; South-West = 35,
South-South = 27, South-East = 22, North-Central = 13,
North-West = 6 and North-East = 6. To increase statistical
power of the study whilst maintaining the zonal propor-
tionality of the participants, a maximum of 20% incre-
ment of the calculated minimum sample size was allowed
for each zone. Hence the maximum expected sample size
was 134. The expected range of participants from each
zone was as follow; South-West zone = 35-42, South-
South zone = 27-33, South-East = 22-27, North Central =
13-16, North-East = 6-8, North-West = 6-8. There was plan
to conduct a follow-up survey in any zone that did not
have its minimum sample size.
For the interview process, the purposes of the study were
explained individually to consecutive attendees at the
SOGON annual conference immediately following regis-
tration and they were solicited to participate in the study.
Those who consented were interviewed with the aid of
self-administered semi-structured questionnaire until the
maximum sample size for each zone was reached. The
questionnaire captured socio-demographic data, length of
practice as a Gynaecologist, geographical location of prac-
tice, menopausal symptoms ever encountered by the
respondents in their practices, the treatments ever offered
for severe menopausal symptoms, their attitude to hor-
mone replacement therapy, and their practice of hormone
replacement therapy.
Data entry, collation and analysis were done with SPSS
statistical software version 10 for descriptive statistics, Z-
test and Chi-Square test as appropriate. P value of = 0.05
was considered significant (at 95% confidence interval).BMC Women's Health 2009, 9:30 http://www.biomedcentral.com/1472-6874/9/30
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This study was approved by the research ethics committee
of the University of Nigeria Teaching Hospital, Enugu
Nigeria.
Results
Out of the 151 eligible conference attendees interviewed,
126 returned their completed questionnaires, giving a
response rate of 83%. Nigeria is divided into 6 health
zones. The zonal distribution of respondents was as fol-
low: South-West = 38, South-South = 32, South-East = 27,
North-Central = 14, North-East = 8 and North-West = 7.
The ages of the participants ranged from 35 years to 61
years with a mean of 47.71 ± 0.84 years. They had prac-
ticed as specialist Gynaecologists for a mean of 6.83 ±
0.54 years with a range of 1 to 34 years. On the average, a
Gynaecologist saw one patient with menopausal symp-
toms every three months (range: 0-3 patients per month).
The main menopausal symptoms they had ever encoun-
tered are shown in Table 1. The commonest symptom was
hot flushes while fracture and urinary symptoms were
uncommonly reported. Table 2 shows the treatments ever
offered by the Gynaecologists for severe menopausal
symptoms. Reassurance and anxiolytics were the common
treatments while HRT was infrequently used. Attitude to
HRT was assessed by asking whether they considered HRT
more effective than the non-hormonal therapies for the
treatment of severe menopausal symptoms. 6.3% agreed
that HRT is more effective than the other treatment
modalities they offered while 93.7% disagreed. The rea-
sons for non-use of HRT are shown in Table 3. Non-avail-
ability of HRT was the reason given by 59.5% of the
respondents for non-use of HRT while only 10.3% of
respondents gave side effects of HRT as their reason for its
non-use.
Discussion
The zonal distribution of participants in this study, espe-
cially the North-South disparity, is consistent with the
national distribution of Gynaecologists in Nigerian
[19,20] and each health zone was represented by at least
20% of its registered Gynaecologists. The study revealed
that although most reported menopausal symptoms
[17,18] are prevalent amongst Nigerian women, the aver-
age Nigerian Gynaecologist sees only a small number of
such cases each year. Whereas hot flushes and psychoso-
matic symptoms are commonly reported, uro-genital
symptoms are less commonly reported while fracture is
rarely reported. The widespread social inhibition and
secrecy about female sexual and genital matters in most
Nigerian communities may be responsible for the low
reporting of sexual and genital symptoms such as vaginal
dryness, dyspareunia, reduced libido and urinary symp-
toms. Women are much less embarrassed about reporting
the non-genital and non-sexual complaints such as hot
flushes, crawling sensation, insomnia, irritability and
depression, hence the apparent higher prevalence of these
non-genital and non-sexual symptoms. Information from
focused group discussions however, revealed that Nige-
rian menopausal women experience the urinary and gen-
ital symptoms. These symptoms are usually presented to
the clergy, spiritualists and traditional medicine men
rather than to the hospitals [18]. Nkwo et.al [17] recorded
Table 1: Menopausal symptoms ever encountered by 
Gynaecologists in Nigeria (N = 126)
Symptoms Number of respondents % respondents
Hot flushes 112 88.9
Insomnia 95 75.4
Depression 73 58
Irritability 71 56.3
Night sweat 70 55.6
Muscle/joint pain 69 54.8
Vaginal dryness 60 47.6
Easy fatigability 54 42.9
Reduced libido 51 40.5
Crawling sensation 48 38.1
Hypertension 33 26.2
Urinary symptoms 21 16.7
Fracture 2 1.6
Table 2: Treatment ever offered by Nigerian Gynaecologists for 
severe menopausal symptoms (N = 126)
Treatment Number of respondents % of respondents
Psychotherapy 114 90.5
Anxiolytics 86 68.3
Analgesics 18 14.3
HRT 10 7.9
Multivitamins 5 4.0
Beta-blockers 4 3.2
Danazol 3 2.4BMC Women's Health 2009, 9:30 http://www.biomedcentral.com/1472-6874/9/30
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only one case of fracture while Agwu et.al [18] reported no
case of fracture in their studies. The black woman is
blessed with a large bone mass which may explain the
protection of Nigerian women from menopausal fracture.
On the other hand, women with menopause-induced
osteoporotic fracture are more likely to be found in ortho-
paedic wards and homes and not in the Gynaecology
clinic and church service (as in the study of Nkwo et.al) or
in a village square meeting (as in the study of Agwu et.al)
and so may have been unintentionally excluded by the
study designs!
The common use of reassurance and anxiolytics for treat-
ing menopausal symptoms was probably influenced by
the high prevalence of psychosomatic symptoms. It is
however more likely that such treatments resulted from a
common but wrong opinion held by many Nigerian doc-
tors in the past that the typical Nigerian women do not
manifest severe menopausal symptoms, hence reassur-
ance evolved as the first line management of menopausal
symptoms. Women who did not respond to reassurance
were given analgesics and anxiolytics as well. By practice
tradition, generations of Nigerian doctors learnt to treat
menopausal symptoms, including severe symptoms, with
reassurance, anxiolytics and analgesics. Although some
societal privileges enjoyed by menopausal women in
some Nigerian communities tend to modulate the expres-
sion of menopausal symptoms; they do not eliminate
them [17]. Indeed, some Nigerian women are known to
have presented with quite severe menopausal symptoms
that are not mitigated by reassurance, anxiolytics or anal-
gesics but by hormonal or effective non-hormonal thera-
pies.
It is worrisome that most of the respondents (93.7% of
them) did not consider HRT more effective than reassur-
ance, anxiolytics and analgesics for severe menopausal
symptoms. This revealed an important knowledge gap
amongst the respondents, leading to suboptimal treat-
ment of these symptoms. The superiority of HRT over pla-
cebos for severe menopausal symptoms is established
[5,7,14,16]. Moreover, reassurance, analgesics, anxiolyt-
ics, and multivitamins are not among the documented
effective non-hormonal therapies for severe menopausal
symptoms [10]; their widespread use by Nigerian Gynae-
cologists is not based on any documented evidence. Cau-
tion in the use of HRT resulted from its potential
cardiovascular and oncogenic side effects following pro-
longed usage [12,15]. Incidentally, only 10.3% of the
respondents withheld the use of HRT for fear of its side
effects.
Patient satisfaction is an important determinant of health
seeking behaviour. Dissatisfaction with treatments offered
by the physicians might be the major reason why only few
women present to them with menopausal symptoms.
Instead, the women seek treatment from alternative
sources including botanical preparations some of which
are quite popular among the women possibly as the result
of their effectiveness in relieving the menopausal symp-
toms. There is an urgent need for Nigerian Gynecologists
to regain the confidence of the Nigerian menopausal
women by offering them effective management of their
menopausal symptoms. The Society of Gynaecology and
Obstetrics of Nigeria (SOGON) and the Post Graduate
Medical Colleges are encouraged to take particular note of
studies on practice patterns and institute mandatory con-
tinuing medical education programmes to bridge
observed gaps and so encourage evidence-based best prac-
tices rather medical practice based on existing traditions.
Conclusion
Most Nigerian Gynaecologists offered suboptimal and
ineffective treatments for severe menopausal symptoms.
This resulted from medical practice that is still strongly
influenced by tradition rather than evidence. Continuing
Table 3: Reasons for non-use of HRT by Nigerian Gynaecologists (N = 126)
Reason Number of respondents % of respondents
Non-availability 75 59.5
High cost 20 15.9
Side effects 13 10.3
Lack of experience 9 7.1
Patients' poor adherence 6 4.8
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medical education of physicians is recommended to
encourage evidence-based best practice of medicine in
Nigeria.
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